Ekso Bionics Holdings Inc
NASDAQ:CHRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ekso Bionics Holdings Inc
NASDAQ:CHRN
|
US |
|
I
|
International Game Technology PLC
DUS:7IG
|
UK |
|
P
|
Poolbeg Pharma PLC
F:7JN
|
UK |
|
C
|
CRISPR Therapeutics AG
F:1CG
|
CH |
Shareholder Yield
Current shareholder yield for 
CHRN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CHRN Price
Ekso Bionics Holdings Inc
| Average Annual Return | -11.72% |
| Standard Deviation of Annual Returns | 98.67% |
| Max Drawdown | -97% |
| Market Capitalization | 42m USD |
| Shares Outstanding | 3 563 381 |
| Percentage of Shares Shorted |
N/A
|
CHRN Return Decomposition
Main factors of price return
Stock Splits
CHRN's latest stock split occurred on Jun 2, 2025
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, CHRN traded at 0.302 per share. Afterward, the share price was about 4.67.
The adjusted shares began trading on Jun 2, 2025. This was stock split number 3 in CHRN's history, following the previous one in Mar 25, 2020.
